Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

26 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Hematology. American Society of Hematology. Education Program
DOIs	https://doi.org/10.1182/hematology.2020000153
Publikationsstatus	Veröffentlicht - 2020

Wissenschaftszweige

@article{1391b34caf1e4c358a1d11b7a11df904,

title = "Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).",

author = "Markus Seidel",

year = "2020",

doi = "10.1182/hematology.2020000153",

language = "English",

journal = "Hematology. American Society of Hematology. Education Program",

issn = "1520-4391",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).

A2 - Seidel, Markus

PY - 2020

Y1 - 2020

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000596547400093

UR - https://pubmed.ncbi.nlm.nih.gov/33275670

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC7727533

U2 - 10.1182/hematology.2020000153

DO - 10.1182/hematology.2020000153

M3 - Research article

C2 - 33275670

SN - 1520-4391

JO - Hematology. American Society of Hematology. Education Program

JF - Hematology. American Society of Hematology. Education Program

ER -